Sun Pharma surges 4%, hits 52-week high; stock rallies 76% from March-low

For the quarter ended June 2020, Sun Pharma reported a surprise loss due to one-time charges.

Sebi starts probe against Sun Pharma, to also reopen insider trading case

The company’s US business posted a 33.5 per cent decline during June 2020 quarter.

New Delhi
Shares of Sun Pharmaceutical Industries surged around 4 per cent to hit a fresh 52-week high of Rs 554.90 on the BSE on Friday. With today's rally, the stock has

Also Read

Sun Pharma board to consider buyback of shares next week

Sun Pharma up nearly 2% post-March quarter nos; here's what brokerages say

Buy Sun Pharma June Futures at Rs 496: Nandish Shah of HDFC Securities

Sun Pharma regains Rs 1 trillion m-cap after surging 38% in four days

Share buyback plan fails to lift Sun Pharma; stock hits over 7-year low

HCC sinks 16% from day's high on Rs 406 crore consolidated net loss in Q1

Nifty Bank gains 3.5%, hits 10-week high; Axis Bank soars 8%, ICICI Bank 5%

Telecom stocks rally; Vodafone Idea surges 17%, Bharti Airtel up 2%

Securities brokers bench their branch office, court customers online

Repco Home Finance freezes at 5% upper circuit; zooms 35% in 10 sessions

First Published: Aug 28 2020 | 1:46 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to